Thalia Therapeutics PLC Announces Acquisition and £2.75 Million Fundraise
Acquisition of oncology company Sanmirna Therapeutics Inc for its clinical-stage Acute Myeloid Leukaemia RNA therapy Acquisition catapults Thalia to a ...
Tag: Chief Executive Officer